US Patent Issued to Neo7Bioscience on Jan. 13 for "Precision-based immuno-molecular augmentation (PBIMA) computerized system, method, and therapeutic vaccine" (American, Bangladeshi Inventors)

ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,525,329, issued on Jan. 13, was assigned to Neo7Bioscience Inc. (Dallas).

"Precision-based immuno-molecular augmentation (PBIMA) computerized system, method, and therapeutic vaccine" was invented by Shamsuddin Sultan Khan (Dhaka zila, Bangladesh), John A. Catanzaro (Rockwall, Texas) and Anton Yuryev (Gaithersburg, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "As disclosed herein a precision based immunomolecular augmentation (PBIMA) high specificity patient profiling networked computer system, rapid therapeutic vaccine design method, and personalized vaccine, which utilizes immuno-molecular biopathway HLA affinity mapping and selection prediction r...